Understanding diabetes-induced cardiomyopathy from the perspective of renin angiotensin aldosterone system

Area of Science:

• Cardiology
• Endocrinology
• Molecular Biology

Background:

• Diabetic cardiomyopathy (DCM) is a specific heart condition in individuals with diabetes mellitus (DM).
• DCM contributes significantly to heart failure and mortality, with increasing prevalence linked to rising DM rates.
• Current therapies for DCM are limited, despite its clinical importance.

Purpose of the Study:

• To review the role of the Renin Angiotensin Aldosterone System (RAAS) in the development of DCM.
• To elucidate the secondary cellular mechanisms, including inflammation, oxidative stress, mitochondrial dysfunction, and autophagy, mediated by RAAS in DCM.
• To identify gaps in current research on DCM and RAAS signaling.

Main Methods:

• Literature review of experimental and clinical studies on DCM and RAAS.
• Analysis of cellular pathways implicated in DCM pathogenesis.
• Identification of research areas requiring further investigation.

Main Results:

• RAAS plays a crucial role in DCM, independent of broader vascular complications.
• RAAS activation triggers secondary mechanisms like inflammation, oxidative stress, mitochondrial dysfunction, and altered autophagy in the heart.
• These RAAS-mediated pathways contribute to cardiomyocyte hypertrophy and diastolic dysfunction, characteristic of DCM.

Conclusions:

• Understanding the intricate role of RAAS in DCM is vital for developing effective therapeutic strategies.
• Targeting RAAS and its downstream pathways may offer new avenues for managing and treating diabetic cardiomyopathy.
• Further research is needed to fully elucidate RAAS signaling in DCM and optimize treatment outcomes.